Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Nimodipine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 8 USDMF, 4 CEP/COS, 1 EU WC, 1 KDMF, 7 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 11 FDA Orange Book, 31 Europe, 1 Canada, 2 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 2 Seqens, 7 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Clariant, 10 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 18 Film Formers & Plasticizers, 14 Taste Masking, 13 Topical, 13 Parenteral, 12 Thickeners and Stabilizers, 12 Chewable & Orodispersible Aids, 11 Direct Compression, 9 Empty Capsules, 8 Solubilizers, 6 Granulation, 5 Co-Processed Excipients, 5 Coloring Agents, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

12 NEWS #PharmaBuzz

12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 25 Finished Drug Prices

MARKET PLACE

9 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 3 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/10/2024	Biophore India Pharmaceuticals Pvt Ltd	India	BIOPHORE INDIA PHARMACEUTICALS PVT LTD	34203	NIMODIPINE	2019-12-03	Active	II	N/A
28/10/2024	Bayer AG	Germany	BAYER CORP	4816	NIMODIPINE CAPS 10MG (bay e 9736)	1982-12-22	Inactive	II	N/A

Nimodipine

Nimodipine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers

8 USDMF

4 CEP/COS

1 EU WC

1 KDMF

7 NDC API

7 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers

11 FDA Orange Book

31 Europe

1 Canada

2 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

13 SPI Pharma

2 Seqens

7 DKSH

1 Faran Shimi Pharmaceutical

2 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

1 Clariant

10 Corel Pharma Chem

2 Finar

5 Gangwal Chemicals

4 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

3 Microlex e.U

2 Nomisma Healthcare

1 Novo Excipients

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

14 Roquette

7 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives

28 Fillers, Diluents & Binders

21 Controlled & Modified Release

18 Film Formers & Plasticizers

14 Taste Masking

13 Topical

13 Parenteral

12 Thickeners and Stabilizers

12 Chewable & Orodispersible Aids

11 Direct Compression

9 Empty Capsules

8 Solubilizers

6 Granulation

5 Co-Processed Excipients

SOLUTION;ORAL - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons